Lagociclovir
Lagociclovir (FLG) is a nucleoside analogue that inhibits wild-type hepatitis B virus (HBV) replication in a human hepatoma cell line permanently expressing HBV.
For research use only. We do not sell to patients.
- CAS No.: 92562-88-4
- Formula: C10H12FN5O3
- Molecular Weight:269.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-13623
EntecavirHBV Inhibitor -
HY-108917
MorphothiadinHBV Inhibitor -
HY-B2116
OsalmidHBV Inhibitor -
HY-16679
Helioxanthin derivative 5-4-2HBV Inhibitor -
HY-112142
AB-423 -
HY-112564
JNJ-632HBV CAM -
HY-100029
Bay 41-4109HBV Inhibitor -
HY-B0955
OxethazaineAnalgesic Agent -
HY-100029A
Bay 41-4109 racemateHBV Inhibitor -
HY-19447
BesifovirHBV Inhibitor -
HY-W018791
BifendateAntioxidant, Anti-HBV Agent -
HY-101954
InarigivirHBV Inhibitor
Biological Activity
Description
IC50 & Target
HBV[1]
In Vitro
Lagociclovir (FLG) (6 days) shows inhibitory activity with IC50s of 8 ± 3.8, 9 ± 2.5, 13 ± 3.4 and 15 ± 6.8 μM against 3TC-R HBV, wt HBV, PMEA-R HBV and 3TC+PMEA-R HBV, respectively in transiently transfected Huh7 cells[1].
Lagociclovir (0-100 μM; 6 days) inhibits the replication of wild-type and drug-resistant mutants of HBV in transiently transfected Huh7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 92562-88-4
-
Molecular Weight 269.23
-
Formula C10H12FN5O3
-
SMILES
O=C(N=C(N)N1)C2=C1N([C@@H]3O[C@H](CO)[C@@H](F)C3)C=N2
-
Synonyms
MIV-210
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Lagociclovir Related Classifications
HY-14844 Related Classifications
Powered by Bioz